A progressive T cell exhaustion program mapped across tissues in patients with lung cancer on immune checkpoint blockade.

ABSTRACT

Immune checkpoint blockade has reached the standard of care for patients with lung cancer. However, its mode of action in patients is still incompletely understood. In this issue, Pai et al. present a temporally and spatially resolved differentiation map of tumor-directed T cells in patients with lung cancer on PD-1 blockade.